Abstract
Diabetes mellitus type 2 is a socially significant disease, which etiologically and pathogenetically is to the greatest extent influenced by body weight. Obesity has become a pandemic of our time. It is most often caused by the imbalance between energy intake and energy expenditure. Excess calories accumulate as fat. In patients with DM type 2, obesity further increases the risk of atherosclerosis, ischemic heart disease, cerebrovascular disease, arterial hypertension, hepatic steatosis, chronic kidney disease, increased mortality. The aim of the present analysis is to determine the frequency of patients with type 2 DM 170 patients with DM type-2 were studied. Of them, 77 with a relative share of 45.% are men, 93 are women, who make up 54.7%. The method of calculating the body mass index, which serves to assess the physical condition of the patients, was applied. After processing the data, it was found that 4.4% of the patients had a normal body weight, 26.5% were overweight, 1st degree obesity - 34.7%, 2nd degree obesity - 20.3% and with obesity of the 3rd degree are 14.1% of the studied patients. Obesity is a serious metabolic disorder that harbors multiple health risk factors that may reduce quality and life expectancy among patients with type-2 DM.
Publisher
Institute of Knowledge Management (Publications)
Reference15 articles.
1. Atlanta (2022).Centers for Disease Control and Prevention. Heart disease: prevent heart disease. 2020..: Centers for Disease Control and Prevention. Accessed 9 Jun
2. Borisova, A.M. (2019). Recommendations for good clinical practice in obesity -BDE
3. Boye KS, Lage MJ, Terrell K.(2020). Healthcare outcomes for patients with type 2 diabetes with and without comorbid obesity.J Diabetes Complications. 34(12): 107730.
4. Cohen, R.V., Pereira, T.V. , Aboud, C.M. , Petry, T.B.Z. , Lopes Correa, J.L. , Schiavon, C.E., Pompílio, C.A., Pechy, F.N.Q., da Costa Silva, A.C.C. , de Melo, F.L.G. , et al.(2020)Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial
5. Dimitrakov,D. (2006).Clinic and therapy of internal diseases